Stockholders' Equity Attributable to Parent of Akso Health Group from 31 Mar 2017 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
Summary
Akso Health Group quarterly Stockholders' Equity Attributable to Parent in USD history and change rate from 31 Mar 2017 to 31 Mar 2025.
  • Akso Health Group Stockholders' Equity Attributable to Parent for the quarter ending 31 Mar 2025 was $199,119,145, a 44% increase year-over-year.
Source SEC data
View on sec.gov
Stockholders' Equity Attributable to Parent, Quarterly (USD)
Stockholders' Equity Attributable to Parent, YoY Quarterly Change (%)

Akso Health Group Quarterly Stockholders' Equity Attributable to Parent (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $199,119,145 +$60,751,761 +44% 31 Mar 2025 20-F 14 Aug 2025 2025 FY
Q3 2024 $200,564,330 +$195,340,922 +3740% 30 Sep 2024 6-K 28 Mar 2025 2025 Q2
Q1 2024 $138,367,384 +$129,642,080 +1486% 31 Mar 2024 20-F 14 Aug 2025 2025 FY
Q3 2023 $5,223,408 -$4,689,437 -47% 30 Sep 2023 6-K 03 Jan 2024 2024 Q2
Q1 2023 $8,725,304 -$3,558,302 -29% 31 Mar 2023 20-F 30 Jul 2024 2024 FY
Q3 2022 $9,912,845 30 Sep 2022 6-K 16 Feb 2023 2023 Q2
Q1 2022 $12,283,606 -$4,987,919 -29% 31 Mar 2022 20-F 14 Jul 2023 2023 FY
Q1 2021 $17,271,525 -$30,829,364 -64% 31 Mar 2021 20-F 29 Dec 2022 2022 FY
Q1 2020 $48,100,889 -$78,402,269 -62% 31 Mar 2020 20-F 28 Jul 2021 2021 FY
Q1 2019 $126,503,158 -$13,539,911 -9.7% 31 Mar 2019 20-F 14 Aug 2020 2020 FY
Q1 2018 $140,043,069 +$116,538,713 +496% 31 Mar 2018 20-F 31 Jul 2019 2019 FY
Q1 2017 $23,504,356 31 Mar 2017 20-F 30 Jul 2018 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.